Daniel M. Lachance
Pfizer (United States)(US)
Publications by Year
Research Areas
Gut microbiota and health, Diet and metabolism studies, Microbial Natural Products and Biosynthesis, Gastrointestinal motility and disorders, Microbial Metabolic Engineering and Bioproduction
Most-Cited Works
- → Experimental and computational optimization of an Escherichia coli co-culture for the efficient production of flavonoids(2016)242 cited
- → ePathOptimize: A Combinatorial Approach for Transcriptional Balancing of Metabolic Pathways(2015)151 cited
- → Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering(2014)137 cited
- → Optimization of naringenin and p ‐coumaric acid hydroxylation using the native E. coli hydroxylase complex, HpaBC(2015)70 cited
- → Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer(2020)57 cited
- → Microbiome-encoded bile acid metabolism modulates colonic transit times(2021)46 cited
- → Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome(2021)43 cited
- → Marker-based assays for studying gut transit in gnotobiotic and conventional mouse models(2021)21 cited
- → Deep learning imaging analysis to identify bacterial metabolic states associated with carcinogen production(2025)15 cited
- → Interpersonal Variability in Gut Microbial Calprotectin Metabolism(2022)4 cited